QUALITY OF LIFE IN PATIENTS WITH PARKINSON'S DISEASE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Parkinson’s disease is a neurodegenerative disease with a wide spectrum of motor and non-motor disorders that affect the quality of life of patients. The health related quality of life (HRQL) is determined by the results of a patient survey that complements the overall clinical picture and provides information about the manifestations of the disease and the effectiveness of its treatment. HRQL is an integral characteristic of the patient’s physical, psychological, emotional and social functioning, based on his subjective perception.

Full Text

Restricted Access

About the authors

T. K Kulua

FSBEI FPE RMACPE of RMH; Center for Extrapyramidal Diseases

Email: doctortaso@gmail.com
PhD, Associate Professor at the Department of Neurology Moscow

N. V Fedorova

FSBEI FPE RMACPE of RMH; Center for Extrapyramidal Diseases

Department of Neurology Moscow

E. V Bril

FSBEI FPE RMACPE of RMH; Center for Extrapyramidal Diseases

Department of Neurology Moscow

References

  1. Новик А.А., Ионова Т.И., Кайнд П. Концепция исследования качества жизни в медицине. СПб.,1999. 140 с.
  2. Quality of life assessment in clinical trials. Ed. M.J. Staquet. Oxford, New York, Tokyo, 1998. 360 p.
  3. Cella D.F, Fairclough D., Bonomi P. et al. Qualitty of life in advance non-small cell lung cancer: results from Eastern Cooperative Oncology Group Study 5592. Proc. ASCO. 1997. P100-10.
  4. Coates A.S., Gebski V., Signorini D., Piirainen H., Anema J.R., van Amstel R.J., Hartog F. For the Ausrtalian New Zealand Breast Cancer Trials Group. Prognostic value of guality of life scores during chemotherapy for advanced dreast cancer. J. Clin. Oncol. 1992;10:1833-38.
  5. Health Organization. International Classification of Functioning, Disability and Health: ICF. Geneva: WHO, 2001.
  6. Martinez-Martin P. An introduction to the concept of «quality oflife» in Parkinsons disease. J. Neurol. 1998;245(Suppl. 1):2-6.
  7. Quality of life and pharmacoeconomics in clinical trials. Ed. Spilker B. 2nd Edition. Philadelphia, 1996. 1259 p.
  8. Martinez-Martin P. What Is Quality of Life and How Do We Measure It? Relevance to Parkinson's Disease and Movement Disorders. Mov. Disord. 2017;32(3):382-92.
  9. Fitzpatrick R., Alonso J. Quality of life in health care: concepts and components. In: Martinez-Martin R, Koller W.C., eds. Quality of life in Parkinson's disease. Barcelona: Masson S.A., 1999. Р 1-15.
  10. Bowling A. Measuring Disease: a review of disease-specific quality of life measurement scales. Philadelphia, 1996. 374 p.
  11. Peto V., Jenkinson C., Fitzpatrick R., Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual. Life Res. 1995;4:241-48.
  12. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., Hyman N. The PDQ-8: Development and validation of a short-form Parkinson's disease questionnaire. Psycholog. Health. 1997;12(6):805-14.
  13. Welsh M., McDermott M.P., Holloway R.G., Plumb S., Pfeiffer R., Hubble J.; Parkinson Study Group. Development and testing of the Parkinson's disease quality of life scale. Mov. Disord. 2003;18(6):637-45.
  14. DeBoer A.G., Wiker W., Speelman J.D. de Haes J.C. Quality of Life in Patients with Parkinson's Disease: Development of a Questionnaire. J. Neurol., Neurosurg. Psychiatry. 1996;61:70-4.
  15. EuroQol group. EuroQol - a new facility for the measurement of health related quality of life. Health Policy. 1990;16:199-208.
  16. Ware J.E., Snow К.К., Kosinski М., Gandek В. Sf-36 Health Survey. Manuel and Interpretation Guide, Lincoln R.I'. QualityMetric Incorporated, 2000.150 p.
  17. Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине. 2-е изд. / Под ред. акад. РАМН Ю.Л. Шевченко. М., 2007. 320 p.
  18. Scaravilli T., Gasparoli E., Rinaldi F., Polesello G., Bracco F. Health-related quality of life and sleep disorders in Parkinson's disease. Neurol. Sci. 2003;24(3):209-10.
  19. Gallanger D.A., Lees A.J., Shrag A. What are the most important nonmotor symptoms in patients with Parkinsons disease and are we missing them? Mov. Disord. 2010;15(15):2493-500.
  20. Keus S., Munneke M., Nijkrake M.J., Kwakkel G., Bloem B.R. Physical therapy in Parkinson's disease: evolution and future challenges. Mov. Disord. 2009;24:1-14.
  21. Ahlskog J. Does vigorous exercise havea neuroprotective effect in Parkinson s disease? Neurology. 2011;77:288-94.
  22. King L.A., Horac F.B. delaying mobility disability in people with Parkinson s disease using a sensorimotor agility exercise program. Phys. Therapy. 2009;89:384-93.
  23. Stocchi F., Brusa L., Vacca L., et al. Sleep disturbances in Parkinson's disease. Eur. J. Neurology. 2000;7(Suppl. 4):21-5.
  24. Larsen J.P., Tandberg E. Sleep disorders in patients with Parkinson's disease: epidemiology and management. CNS Drugs. 2001; 15(4):267-75.
  25. Friedman J.H., Chou K.L. Sleep and fatigue in Parkinson's disease. Parkinsonism Relat. Disord. 2004;10(Suppl. 1):S27-35.
  26. Chaudhuri K.R. Nocturnal symptom complex in Parkinson's disease and its management. Neurology. 2003;61:S17-23.
  27. Pal P.K., Calne S., Samii A., Fleming J.A. A review of normal sleep and its disturbances in Parkinson's disease. Parkinsonism Related Disord. 1999;5(1-2):1-17.
  28. Starkstein E., Dragovic M., Jorge R., Brockman S., Merello M., Robinson R.G., Bruce D., Wilson M. Diagnostic criteria for depression in Parkinsons disease: a study of symptom pattern using latent class analysis. Mov.Dis.2011;26(12): 2239-45.
  29. Jordan L.L., Zahodne L.B., Okun M.S. Hedonistic and behavioral deficits associated with apathy in Parkinsons disease: potential treatment implications. Mov.Dis.2013;28:1301-304.
  30. Dissanayaka N.N., White E., O'Sullivan J.D., Marsh R., Pachana N.A., Byrne G.J.The clinical spectrum of anxiety in Parkinsons disease. Mov. Dis.2014;8:967-75.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies